Efficacy and Safety of Dapagliflozin in Patients with Inadequately Controlled Type 1 Diabetes. DEPICT-2 Study. ADA Report juni 24, 2018 3:23 e m Läs mer »
ADA Report. Intense Multifactorial Treatment for Type 2 Diabetes Shown to be Cost Effective 21 yrs follow-up juni 24, 2018 2:20 e m Läs mer »
ADA Report. Experts debate the value of cardiovascular outcomes trials in diabetes juni 23, 2018 12:06 e m Läs mer »
